Gaviola, Phedilyn .
HRN: 15-71-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/22/2023
AMPICILLIN 500MG (VIAL)
09/22/2023
09/23/2023
IV
2gm
Q6
PROM
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes